Novo Holdings A/S’s Xenon Pharmaceuticals XENE Stock Holding History

Novo Holdings A/S’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.2M	Buy	+485,438	New	+$22.4M	2.29%	18
2017 Q3	–	Sell	-127,563	Closed	-$402K	–	18
2017 Q2	$402K	Hold	127,563	–	–	0.05%	21
2017 Q1	$510K	Hold	127,563	–	–	0.05%	21
2016 Q4	$982K	Hold	127,563	–	–	0.09%	21
2016 Q3	$1.03M	Hold	127,563	–	–	0.09%	16
2016 Q2	$753K	Hold	127,563	–	–	0.08%	17
2016 Q1	$892K	Hold	127,563	–	–	0.1%	17
2015 Q4	$1.03M	Hold	127,563	–	–	0.1%	14
2015 Q3	$1.05M	Hold	127,563	–	–	0.11%	19
2015 Q2	$1.47M	Hold	127,563	–	–	0.11%	19
2015 Q1	$2.15M	Hold	127,563	–	–	0.18%	14
2014 Q4	$2.52M	Buy	+127,563	New	+$1.87M	0.2%	15

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Novo Holdings A/S's XENE Position: Q1 2026 in Review

Novo Holdings A/S opened a new position in Xenon Pharmaceuticals (XENE) in Q1 2026: 485,438 shares worth $28.2M. The stake represents 2.29% of the portfolio and ranks #18 among its holdings. This is a return to the name: Novo Holdings A/S previously reported a position in XENE as recently as Q2 2017.

Novo Holdings A/S first reported a position in XENE in Q4 2014 and has held it in 12 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

Novo Holdings A/S held 485,438 shares of Xenon Pharmaceuticals worth $28.2M as of Q1 2026.
Xenon Pharmaceuticals was a new Novo Holdings A/S position in Q1 2026.
Xenon Pharmaceuticals made up 2.29% of Novo Holdings A/S's portfolio in Q1 2026, its #18 holding.
Novo Holdings A/S first reported a position in Xenon Pharmaceuticals in Q4 2014 and has held it in 12 quarters since.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Novo Holdings A/S's 13F filing for Q1 2026, filed 15 May 2026.